首页 > 专栏 > The Lancet The Lancet 共 175 条资讯 [Perspectives] Barbara Prainsack: practical utopianism for healthier societies 2026-06-28 11:43:09 [Comment] The role of product safety and liability law in governing digital determinants of health 2026-06-28 11:43:09 [Series] The public health challenges of children's and adolescents’ digital media use: applying the digital determinants of health as an interpretive framework 2026-06-28 11:43:09 [Series] Governing the digital determinants of health for children and young people: a global public health imperative 2026-06-28 11:43:09 [Series] The digital determinants of health: a new era for global public health 2026-06-28 11:43:09 [Editorial] Digital technology for health, not harm 2026-06-28 11:43:09 [Articles] Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial 2026-06-28 11:43:09 [Articles] 8 weeks versus 12 weeks of sofosbuvir–velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India 2026-06-28 11:43:09 [Correspondence] Declare the climate crisis a Public Health Emergency of International Concern 2026-06-28 11:43:09 [Articles] Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial 2026-06-28 11:43:09 [Clinical Rounds] A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report 2026-06-28 11:43:09 [Comment] A novel and effective treatment for fibrodysplasia ossificans progressiva 2026-06-28 11:43:09 [Articles] Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial 2026-06-28 11:43:09 [Articles] Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial 2026-06-28 11:43:09 [Comment] Adjuvant radiotherapy for atypical meningioma 2026-06-28 11:43:09 [Correspondence] From isolation to burial: dignity in the Bundibugyo virus disease response 2026-06-28 11:43:09 [Comment] Healthy donor faecal microbiota transplantation in irritable bowel syndrome: interpreting negative findings 2026-06-28 11:43:09 [Articles] Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial 2026-06-28 11:43:09 [Comment] The arts belong at the heart of health policy 2026-06-28 11:43:09 [Viewpoint] The arts as a global health resource: key priorities for future research 2026-06-28 11:43:09 123…9下一页 » 相关分类 The Lancet ScienceDirect Publication: The Lancet ScienceDirect Publication: The Lancet Oncology The Lancet Child & Adolescent Health The Lancet Diabetes & Endocrinology The Lancet Digital Health The Lancet Gastroenterology & Hepatology The Lancet Global Health The Lancet HIV The Lancet Haematology The Lancet Healthy Longevity The Lancet Infectious Diseases The Lancet Microbe The Lancet Neurology The Lancet Oncology The Lancet Planetary Health The Lancet Psychiatry